EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Path Less Traveled: Targeting Rare Driver Oncogenes in Non–Small-Cell Lung Cancer

Sun Min Lim, Jii Bum Lee iD, Yuko Oya, Jorn Nutzinger, Ross Soo iD

JCO Oncology Practice · 2024-01 · 20 (1) · 47-56

DOI: 10.1200/op.23.00273 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JCO Oncology Practice, 2024-01. Verfasst von Sun Min Lim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 103 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past decade, tremendous efforts have been made in the development of targeted agents in non–small-cell lung cancer (NSCLC) with nonsquamous histology. Pivotal studies have used next-generation sequencing to select the patient population harboring oncogenic driver alterations that are targetable with targeted therapies. As treatment paradigm rapidly evolves for patients with rare oncogene-driven NSCLC, updated comprehensive overview of diagnostic approach and treatment options is paramount in clinical settings. In this review article, we discuss the epidemiology, molecular testing, and landmark clinical trials addressing the targeted agents for ROS1 rearrangement, METex14 skipping mutation, EGFR exon 20 insertion, KRAS G12C mutation, HER2 mutation, RET fusion, NTRK fusion, and BRAF mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsAntineoplastic AgentsHumansProtein-Tyrosine KinasesProto-Oncogene ProteinsOncogenes

Substanzen

Protein-Tyrosine KinasesProto-Oncogene ProteinsAntineoplastic Agents

Autor:innen und Institutionen

  • Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Department of Respiratory Disease, Fujita Health University, Toyoake, Japan.
  • Department of Haematology-Oncology, National University Cancer Institute, Singapore.

ORCID-Profile: Jii Bum Lee, Ross Soo

Zitieren

APA

Lim, S. M., Lee, J. B., Oya, Y., Nutzinger, J., & Soo, R. (2024). Path Less Traveled: Targeting Rare Driver Oncogenes in Non–Small-Cell Lung Cancer. JCO Oncology Practice, 20(1), 47-56. https://doi.org/10.1200/op.23.00273

Vancouver

Lim SM, Lee JB, Oya Y, Nutzinger J, Soo R. Path Less Traveled: Targeting Rare Driver Oncogenes in Non–Small-Cell Lung Cancer. JCO Oncology Practice. 2024;20(1):47-56. doi:10.1200/op.23.00273

BibTeX
@article{Lim2024,
  author = {Lim, Sun Min and Lee, Jii Bum and Oya, Yuko and Nutzinger, Jorn and Soo, Ross},
  title = {Path Less Traveled: Targeting Rare Driver Oncogenes in Non–Small-Cell Lung Cancer},
  journal = {JCO Oncology Practice},
  year = {2024},
  volume = {20},
  number = {1},
  pages = {47--56},
  doi = {10.1200/op.23.00273}
}
Kostenlos starten →